Surmodics
SRDX
SRDX was delisted on the 18th of November, 2025.
148 hedge funds and large institutions have $607M invested in Surmodics in 2021 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 39 increasing their positions, 60 reducing their positions, and 19 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.2% less ownership
Funds ownership: 90.37% → 90.17% (-0.2%)
3% less funds holding
Funds holding: 152 → 148 (-4)
13% less capital invested
Capital invested by funds: $697M → $607M (-$90.4M)
21% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 19
35% less repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 60
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$7.62M |
| 2 |
TI
Trigran Investments
Northbrook,
Illinois
|
+$7.22M |
| 3 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
+$4.6M |
| 4 |
BlackRock
New York
|
+$2.88M |
| 5 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$1.39M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$5.56M |
| 2 |
Renaissance Technologies
New York
|
-$3.52M |
| 3 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$2.94M |
| 4 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$2.85M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$2.12M |
SRDX Hedge Fund Activity: Q4 2021 in Review
148 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Surmodics (SRDX) for Q4 2021, worth a combined $607M — down 13% from $697M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of SRDX and 15 opened new positions — a net loss of 4 holders — while 60 trimmed existing stakes and 39 added.
The largest buyer was Soleus Capital Management, adding an estimated $7.62M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $5.56M sold.
- 148 institutional investors held Surmodics (SRDX) as of Q4 2021, down from 152 in Q3 2021.
- Funds reported $607M of Surmodics stock for Q4 2021, down 13% quarter-over-quarter.
- 15 funds opened new Surmodics positions in Q4 2021 and 19 closed out, a net change of -4 holders.
- The largest Surmodics buyer in Q4 2021 was Soleus Capital Management, an estimated $7.62M added.
- The largest Surmodics seller in Q4 2021 was Adage Capital Partners, an estimated $5.56M sold.
Based on aggregated 13F filings for Q4 2021.